Known targets — ChEMBL curated mechanism
FGFR1FGFR2FGFR3FGFR4FLT1FLT4KDRPDGFRAPDGFRB
The experimentally established mechanism targets of Zinc Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | HBB | P68871 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 2/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL22581629 | 0.96 | BBOX1 (0.36) | BBOX1KDM4EMAPTALOX15TSHR | |
| SCHEMBL9001604 | 0.91 | BBOX1 (0.38) | BBOX1KDM4EMAPTALOX15TSHR | |
| SCHEMBL20583852 | 0.91 | BBOX1 (0.38) | BBOX1KDM4EMAPTALOX15TSHR | |
| SCHEMBL2367141 | 0.91 | BBOX1 (0.38) | BBOX1KDM4EMAPTALOX15TSHR | |
| SCHEMBL22581623 | 0.91 | BBOX1 (0.38) | BBOX1KDM4EMAPTALOX15TSHR | |
| SCHEMBL20533681 | 0.91 | BBOX1 (0.38) | BBOX1KDM4EMAPTALOX15TSHR | |
| SCHEMBL20533678 | 0.91 | — | — | |
| SCHEMBL20533647 | 0.91 | BBOX1 (0.38) | BBOX1KDM4EMAPTALOX15TSHR | |
| SCHEMBL1552464 | 0.91 | BBOX1 (0.38) | BBOX1KDM4EMAPTALOX15TSHR | |
| SCHEMBL19809549 | 0.91 | BBOX1 (0.38) | BBOX1KDM4EMAPTALOX15TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110010373-B | Electrode zinc embedding treatment method and application thereof in preparation of battery type super capacitor | 中国科学院福建物质结构研究所 | 2021-02-19 | — | — | CN | claimed |
| CN-109994322-B | Battery type super capacitor and application thereof | 中国科学院福建物质结构研究所 | 2020-12-29 | — | — | CN | claimed |
| CN-109037794-B | Rechargeable battery | 刘小林 | 2020-11-24 | — | — | CN | claimed |
| US-20200343595-A1 | RECHARGEABLE BATTERY | LIU, XIAOLIN (CN) | 2020-10-29 | — | — | US | claimed |
| CN-107910195-B | Hybrid super capacitor | 刘小林 | 2020-07-28 | — | — | CN | claimed |
| CN-109037794-A | Rechargeable battery | 南京蔚速科技有限公司 | 2018-12-18 | — | — | CN | claimed |
| US-20130059885-A1 | Method For Preparation Of Pitavastatin and Pharmaceutical Acceptable Salts Thereof | CADILA HEALTHCARE LIMITED (IN) | 2013-03-07 | — | — | US | claimed |
| US-20120022102-A1 | METHOD FOR PREPARATION OF PITAVASTATIN AND ITS PHARMACEUTICAL ACCEPTABLE SALTS THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2012-01-26 | — | — | US | claimed |
| WO-2011089623-A2 | PROCESS FOR PREPARING PITAVASTATIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2011-07-28 | — | — | WO | claimed |
| WO-2009047577-A1 | PROCESS FOR PREPARATION OF ROSUVASTATIN ZINC SALT | EGIS GYÓGYSZERGYÁR Nyilvánosan Müködö Részvénytársaság (HU) | 2009-04-16 | — | — | WO | claimed |
| CN-121260953-A | Electrolyte and zinc ion battery | 北京中科行发医疗科技有限公司 | 2026-01-02 | — | — | CN | disclosed |
| CN-118589062-A | Vanadium-based water-based zinc ion battery | 北京化工大学 | 2024-09-03 | — | — | CN | disclosed |
| CN-110010373-B | Electrode zinc embedding treatment method and application thereof in preparation of battery type super capacitor | 中国科学院福建物质结构研究所 | 2021-02-19 | — | — | CN | disclosed |
| CN-109994322-B | Battery type super capacitor and application thereof | 中国科学院福建物质结构研究所 | 2020-12-29 | — | — | CN | disclosed |
| CN-109037794-B | Rechargeable battery | 刘小林 | 2020-11-24 | — | — | CN | disclosed |
| US-20120022102-A1 | METHOD FOR PREPARATION OF PITAVASTATIN AND ITS PHARMACEUTICAL ACCEPTABLE SALTS THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2012-01-26 | — | — | US | disclosed |
| WO-2011089623-A2 | PROCESS FOR PREPARING PITAVASTATIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2011-07-28 | — | — | WO | disclosed |
| US-6830704-B2 | Contains a Lewis acid metal salt and a compound having clathrating ability. | TOAGOSEI CO., LTD. (JP) | 2004-12-14 | — | — | US | disclosed |
| US-20030135016-A1 | Contains a Lewis acid metal salt and a compound having clathrating ability. | TOAGOSEI CO., LTD. | 2003-07-17 | — | — | US | disclosed |
| US-6547985-B1 | Adhesive mixture | TOGOSEI CO., LTD. (JP) | 2003-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130059885-A1 | Method For Preparation Of Pitavastatin and Pharmaceutical Acceptable Salts Thereof | GANAB, SLC30A5, TPP1 | BBOX1 3824/4885KDM4E 1009/4885MAPT 2105/4885 |
| US-20120022102-A1 | METHOD FOR PREPARATION OF PITAVASTATIN AND ITS PHARMACEUTICAL ACCEPTABLE SALTS THEREOF | GANAB, SLC30A5, TPP1 | BBOX1 3370/4885KDM4E 781/4885MAPT 2342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.